Why Most Grant-to-Spinout Transitions Fail Before the Company Even Forms
The gap between a funded research project and a viable spinout company destroys more potential than bad science ever does. Here's what actually goes wrong.
A. Kovacs6 posts tagged spinouts from Commercializing Science.
Sublicensing provisions in university license agreements often hand control to licensees by default. Here's what to negotiate before it's too late.
A. KovacsField-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsEquity splits between founders, universities, and early investors derail more spinouts than bad science. Here's what actually works.
A. KovacsHow mismatched expectations between VCs and university spinouts create a death spiral during due diligence.
A. KovacsUniversity research dies between the lab and the market at staggering rates. The reasons are structural, not accidental, and most proposed fixes miss the point entirely.
A. Kovacs